Volume regulatory Cl Ϫ channels are key regulators of ischemic preconditioning (IPC). Because Cl Ϫ efflux must be balanced by an efflux of cations to maintain cell membrane electroneutrality during volume regulation, we hypothesize that I K1 channels may play a role in IPC. We subjected cultured cardiomyocytes to 60-minute simulated ischemia (SI) followed by 60-minute of simulated reperfusion (SR) and assessed percent cell death using trypan blue staining. Ischemic preconditioning (10-minute SI/10-minute SR) significantly (PϽ0.0001) reduced the percent cell death in nontransfected cardiomyocytes [IPC CM 18.0Ϯ2.1% versus control (C CM ) 48.3Ϯ1.0%]. IPC protection was not altered by overexpression of the reporter gene (enhanced green fluorescent protein, EGFP). However, overexpression of dominant-negative Kir2.1 or Kir2.2 genes using adenoviruses (AdEGFPKir2.1DN or AdEGFPKir2.2DN) encoding the reporter gene EGFP prevented IPC protection [both IPC CM ϩAdEGFPKir2.1DN 45.8Ϯ2.3% (meanϮSEM) and IPC CM ϩAdEGFPKir2.2DN 47.9Ϯ1.4% versus IPC CM ; PϽ0.0001] in cultured cardiomyocytes (nϭ8 hearts). Transfection of cardiomyocytes with AdEGFPKir2.1DN or AdEGFPKir2.2DN did not affect cell death in control (nonpreconditioned) cardiomyocytes (both C CM ϩ AdEGFPKir2.1DN 45.8Ϯ0.7% and C CM ϩAdEGFPKir2.2DN 46.2Ϯ1.3% versus C CM ; not statistically significant). Similar effects were observed in both cultured (nϭ5 hearts) and freshly isolated (nϭ4 hearts) ventricular cardiomyocytes after I K1 blockade with 20 mol/L BaCl 2 plus 1 mol/L nifedipine (to prevent Ba 2ϩ uptake). Nifedipine alone neither protected against ischemic injury nor blocked IPC protection. Our findings establish that I K1 channels play an important role in IPC protection. (Circ Res. 2004;95:325-332.) 
I schemic preconditioning (IPC) is a strong native protective mechanism that limits the amount of necrosis during a subsequent prolonged ischemia and reperfusion period. 1 Although much is known about the cell membrane receptors and intracellular pathways involved in IPC, [2] [3] [4] [5] very little is known about the end effector(s) of IPC. Finding the end effector(s) of IPC is important to guide the development of new specific therapeutic approaches to protect the ischemic myocardium.
Our recent results in cardiomyocytes established that blockade of Cl Ϫ channels inhibits cell volume regulation following hypoosmotic stress (regulatory volume decrease, RVD), 6, 7 which results in loss of protection against necrosis induced by both ischemic 8 and pharmacological preconditioning. 6 Because accumulation of metabolic by-products is responsible for increasing the intracellular osmotic load in ischemia and thereby increasing water uptake in cardiomyocytes, and because IPC only produces a small reduction in the estimated osmotic load in ischemic cardiomyocytes, 7 we hypothesized that enhanced cell volume regulation as a result of Cl Ϫ channel activation plays a significant role in the protection induced by IPC. Consistent with this hypothesis, IPC substantially reduces hypoosmotic-induced and ischemia-induced cell swelling in cardiomyocytes. 7 In order for Cl Ϫ ion movement to effectively regulate cellular volume, electroneutrality dictates that positively charged ions must accompany chloride ions. Although any cation could act as a counter-ion for Cl Ϫ , K ϩ is the most abundant intracellular cation. In addition, extracellular K ϩ increases by 2-to 3-fold during ischemia as a result of K ϩ efflux from cardiomyocytes. 9 Passage of K ϩ out of the cardiomyocyte could occur through multiple K ϩ channels. Of these, voltage-gated channels such as for transient outward currents and delayed rectifier current are only open for relatively brief periods. 10 Moreover, myocardium becomes electrically quiescent (ie, approaching resting membrane potential) during severe and persistent ischemia, thus minimizing the activation of voltage-gated K ϩ currents. On the other hand, inward rectifier potassium (IRK) currents remain open during quiescence that increases during ischemia as a result of elevated extracellular K ϩ levels. Several IRK currents exist in heart: strongly rectifying currents (I K1 ), G protein-regulated currents (I KAch ), ATP-sensitive currents (I KATP ), and Na ϩ -sensitive currents (I KNa ) K ϩ channels. 11, 12 In the heart, I KAch is primarily expressed in atrial and nodal cardiomyocytes, 10, 11 whereas I KNa channels only open when [Na ϩ ] i reaches a very high level (30 mmol/L). 13, 14 Thus, I K1 and sarcolemmal I KATP (sI KATP ) appear to be the most attractive candidates to allow K ϩ to move with Cl Ϫ to regulate cardiomyocyte volume.
In the present study, we assessed whether I K1 channels are involved in the protection induced by IPC against ischemia/ reperfusion injury in fresh and cultured rabbit ventricular cardiomyocytes. We found that pharmacological inhibition of I K1 abolished IPC cardioprotection and this finding does not appear to be related to nonspecific inhibition affecting sI KATP . Moreover, knockdown of I K1 channels by adenovirus transfection of either dominant-negative Kir2.1(C122S) gene (AdEGFPKir2.1DN) or the dominant-negative Kir2.2(C123S) gene (AdEGFPKir2.2DN) completely blocked the protection of IPC against cell death caused by the subsequent long period of simulated ischemia and reperfusion. To our knowledge, no previous published study has established a role for the I K1 channel as a potential end effector in the cardioprotection of IPC.
Materials and Methods

Isolation of Ventricular Cardiomyocytes
Calcium tolerant-isolated cardiomyocytes used in these studies were obtained from New Zealand white rabbit (weightϭ3 to 3.5 kg) hearts by enzymatic dissociation using a method previously described 8, 15 (for details of cardiomyocyte isolation, see the expanded Materials and Methods in the online data supplement available at http:// circres.ahajournals.org). Animal protocols conformed to the Guide for the Care and Use of Laboratory Animals published by NIH (publication No. 85-23, 1996) . All animals were obtained from Reimens Fur Ranches Ltd. (St. Agatha, Ontario, Canada).
Recombinant Adenoviruses
To define the participation of the I K1 channels in the protection induced by IPC, we used three different type-5 recombinant adenoviruses, AdEGFP, AdEGFPKir2.1(C122S) (AdEGFPKir2.1DN), and AdEGFPKir2.2(C123S) (AdEGFPKir2.2DN), which have been extensively studied in our laboratory. 16, 17 These recombinant adenoviruses encode a bidirectional construct, which includes a marker protein (enhanced green fluorescence protein, EGFP) used to confirm the transfer of each gene into cardiomyocytes. However, only the AdEGFPKir2.1DN and AdEGFPKir2.2DN viruses have a dominant-negative (DN) mutant, either the Kir2.1(C122S) or Kir2.2(C123S) gene, respectively, to knockdown the I K1 channel (for details, see online data supplement).
Single Cell Electrophysiology Studies in Isolated and Cultured Cardiomyocytes
After ventricular cardiomyocytes were prepared as described, they were cultured on laminin-coated glass coverslips at a density of 4 to 5ϫ10 4 cells/35-mm dish in serum-free culture media 199 with Earle's salts. After allowing 2 hours for cardiomyocyte attachment, the culture media was exchanged and the cells were either used directly for patch-clamp recordings (see later) or infected either with AdEGFP 25 TCID 50 /cardiomyocyte, AdEGFPKir2.1DN 5 TCID 50 / cardiomyocyte, or AdEGFPKir2.2DN 5 TCID 50 /cardiomyocyte for patch-clamp recording after 48 hours in culture. Transfection efficiency using these viruses was Ն98% as assessed by EGFP phenotypic expression. After either 2 or 48 hours in culture, glass coverslips containing laminin-attached cardiomyocytes were transferred into a small recording chamber mounted on the stage of an inverted microscope (Olympus IX 70) and whole-cell patch-clamp recording of I K1 current was performed as we have previously described 16 (see online data supplement).
Ischemic Preconditioning Studies in Freshly Isolated Cardiomyocytes
After isolation (nϭ4 hearts), cardiomyocytes were divided in several groups and subjected to the following protocol (also see the online Figure in the online data supplement). First, all cardiomyocytes were transferred into separate wells in a multi-well dish and then incubated at 37°C in a 100% O 2 atmosphere for 30 minutes (stabilization period). Then, preconditioned cardiomyocytes were subjected to 10 minutes of simulated ischemia (SI, pelleting cells under an oil layer in a 1.5-mL Eppendorf tube and followed by incubation in a 37°C water bath) followed by 20 minutes of simulated reperfusion (SR, resuspension of cell pellet in oxygenated S-MEM medium). Control (nonpreconditioned) and baseline (incubation in S-MEM medium at 37°C without SI or SR) cardiomyocytes were incubated in S-MEM medium for another 30 minutes to match each group protocol in time. Next, each group of cardiomyocytes was subjected to 45minute SI/60-minute SR. I K1 channels were blocked with 20 mol/L Ba 2ϩ (used as BaCl 2 ), given during the 45-minute SI period. To avoid toxic effects and any other nonspecific effect derived from Ba 2ϩ uptake into cardiomyocytes via L-type calcium channels, we concurrently administered the L-type calcium channel blocker nifedipine (1 mol/L). The Ba 2ϩ concentration used was based on the concentration-response electrophysiology study performed in freshly isolated rabbit ventricular cardiomyocytes ( Figure 1 ) with the Ba 2ϩ concentration estimated Ϸ20 mol/L chosen to produce an estimated 80% to 90% inhibition of I K1 under the conditions of simulated ischemia (see online data supplement for details). Cell viability (as measured by percentage of dead cardiomyocytes) was determined after 45-minute SI and 60-minute SR by trypan blue staining as previously described. 8 We counted at least 300 cardiomyocytes (live and dead) at each time point in each group.
Primary Culture of Cardiomyocytes
Ventricular cardiomyocytes were cultured using a method we have previously described 6, 7 (for details see online data supplement).
Ischemic Preconditioning Studies in Barium-Blocked I K1 Channels in Cultured Cardiomyocytes
After 48 hours in culture, cardiomyocytes were subjected to the following experimental protocol (also see the online Figure in the online data supplement). After 30-minute stabilization in culture medium 199, cardiomyocytes were subjected to 60-minute simulated ischemia (SI) and 60-minute simulated reperfusion (SR). Prolonged ischemia was simulated by incubating cardiomyocytes in a severely hypoxic (Ϸ8% O 2 ), HEPES-based solution (SI solution) containing (in mmol/L) 139 NaCl, 12.0 KCl, 0.5 MgCl 2 , 0.9 CaCl 2 , 5 HEPES, 10 2-deoxy-D-glucose, and 20 lactate, 0.1% BSA (pH 6.5, at 37°C), in a 100% N 2 atmosphere. Reperfusion was simulated by incubation of cardiomyocytes in oxygenated medium 199 (pH 7.4, at 37°C). KCl concentration was increased from physiological levels (4.7 mmol/L) to 12 mmol/L to simulate the high K ϩ concentration environment in myocardium during ischemia; lactate was added to the SI solution to simulate the build up of metabolic end products and low pH during ischemia. Cardiomyocytes were preconditioned by incubating them in an IPC solution (a solution similar to the SI solution with the exception that it has no lactate added, pH 7.4, and contained 4.7 mmol/L of KCl) for 10 minutes followed by a 10-minute SR before the 60-minute SI. Control cardiomyocytes were not preconditioned. I K1 channels were blocked with Ba 2ϩ (20 mol/L BaCl 2 ) administered during the 60-minute SI and in the presence of 1 mol/L nifedipine. All cardiomyocytes (control, preconditioned, and baseline) received the same treatments (BaCl 2 ϩnifedipine, nifedipine alone, or no drug). Baseline cardiomyocytes were incubated in medium 199 for the duration of protocols to determine the effect of drugs on cell viability under oxygenated conditions. Cardiomyocyte viability was determined by trypan blue staining before ischemia and end of 60-minute SI/60-minute SR, as described in the online data supplement.
Ischemic Preconditioning Studies in I K1 Channel Knockdown Cultured Cardiomyocytes
After 2 hours in culture, cardiomyocytes were infected with one of three recombinant adenoviruses: AdEGFP, AdEGFPKir2.1DN, or AdEGFPKir2.2DN. Culture dishes that did not meet the criteria for effective rate of cell transfection (Ն98% of cardiomyocytes showing EGFP fluorescence) were not used for the study. Transfected cardiomyocytes were included in nine different groups: (1) EGFPtransfected control (C CM ϩAdEGFP); (2) EGFP-transfected preconditioned (IPC CM ϩAdEGFP);
Matched-control cardiomyocytes were used for nontransfected groups (preconditioned, control, and baseline). All cardiomyocytes were subjected to the same standard SI/SR and cell viability protocols described above for the barium studies in cultured cardiomyocytes. To establish an unbiased reproducibility of the results, we performed these studies in two stages: (1) nonblinded experiments to the observer (nϭ4 hearts) and (2) blinded experiments to the observer (nϭ4 hearts). Because the same outcome was observed in the two stages, we pooled these data.
Effect of Sarcolemmal I KATP Channel Inhibition on Ischemic Preconditioning in Cardiomyocytes
To determine if sI KATP channels may also have a role in IPC protection against ischemia/reperfusion injury in freshly isolated and 48-hour cultured cardiomyocytes, we inhibited sI KATP channels with 30 mol/L HMR1098 (a gift from Adventis Pharma Deutschland GmbH, Germany). All cardiomyocytes were subjected to the same control, preconditioning and baseline protocols described for the barium experiments. HMR1098 was added to the medium just before the 60-minute SI. Cardiomyocyte viability was determined as described in the barium studies.
Statistical Analysis
All data are summarized and expressed as meanϮSEM. All cardiomyocyte data were first tested for normality and homogeneity of variance. ANOVA analysis followed by Scheffe post hoc test was performed to determine significant differences (PϽ0.05) among groups and between two groups, respectively. Where the criteria for parametric analysis were not met, we performed a nonparametric analysis (Kruskal-Wallis followed by Mann-Whitney U) to determine whether a significant difference (PϽ0.05) existed between two groups.
Results
Inhibition of I K1 Conductance by Barium and Dominant-Negative Transfection With AdEGFPKir2.1DN
In these studies, inward rectifier K ϩ currents were inhibited in two ways. Inward rectifier K ϩ currents (I K1 ) measured at Ϫ110 mV were inhibited by 90% at steady state with BaCl 2 (10 mol/L) as shown in Figure 1 (see "Discussion" and online data supplement for an estimate of I K1 inhibition of 86% to 87% under simulated ischemia at 20 mol/L Ba 2ϩ in the preconditioning protection studies). As expected, I K1 current density decreased under culture conditions (Figure 1 ). Cardiomyocyte I K1 conductance elicited at Ϫ110 mV was reduced by approximately 50% (control fresh cardiomyocytes Ϫ17.9Ϯ1.09 pA/pF versus control 48 hour-cultured cardiomyocytes Ϫ8.35Ϯ0.87 pA/pF; PϽ0.05) after 48 hours in culture. I K1 currents were further reduced by transfection of cultured ventricular cardiomyocytes with recombinant adenovirus expressing Kir2.1DN or Kir2.2DN genes along with the EGFP. Adenovirus expressing EGFP alone (AdEGFP) were used as controls and AdEGFP had no effect on I K1 current density after 48 hours in cultured cardiomyocytes compared with nontransfected control cardiomyocytes cultured for the same period of time (Figure 1 ). Transfection with either AdEGFPKir2.1DN or AdEGFPKir2.2DN resulted in a significant reduction (Ϸ50%) of I K1 current density (AdEGFPKir2.1DN Ϫ3.62Ϯ0.31 or AdEGFPKir2.2DN Ϫ4.49Ϯ0.21 versus AdEGFP Ϫ7.95Ϯ0.53; PϽ0.05) ( Figure  1 ). BaCl 2 , administered at a concentration of 10 mol/L to AdEGFP transfected cardiomyocytes, blocked I K1 current density to about the same extent as in freshly isolated cardiomyocytes (data not shown). Neither Ba 2ϩ nor AdEGFPKir2.1DN/AdEGFPKir2.2DN transfection had any effect on average membrane potential (see online data supplement for details).
Blockade of Ischemic Preconditioning Protection by Pharmacological Inhibition of I K1 Channels in Ventricular Cardiomyocytes
The effects of 20 mol/L Ba 2ϩ , sufficient to inhibit I K1 current by about 86% to 87% (see Discussion and online data supplement) on protection against cell death by IPC in freshly isolated cardiomyocytes is shown in Figure 2A . As expected, there was no difference in the percentage of dead cardiomyocytes either after the initial stabilization period or immediately before the long SI among all the groups. Similarly, no difference among all the baseline groups (with and without barium) was found with regard to the percentage of dead cardiomyocytes at the end of the experimental period. As we have previously shown, 8 ischemic preconditioning (IPC) significantly (PϽ0.0001) reduced the percentage of dead cardiomyocytes after 45 minutes of SI and 60 minutes of SR, when compared with untreated control cardiomyocytes [IPC versus control (C)]. This amount of protection conferred by IPC in freshly isolated cardiomyocytes (46% reduction in mortality; Figure 2A) was similar to the amount of IPC protection observed in 48-hour cultured cardiomyocytes (49% reduction in mortality, Figure 2B ) and with single-cycle IPC protection in vivo in rabbit hearts (42% reduction in infarct size) 18 previously reported from our laboratory. Blockade of I K1 channels with 20 mol/L BaCl 2 (in the presence of 1 mol/L nifedipine) significantly (PϽ0.0001) reduced the protection induced by IPC (IPCϩBaCl 2 ), while having no effect on treated control cardiomyocytes (CϩBaCl 2 ). Nifedipine alone did not protect against ischemia or block IPC-induced protection (CϩNF and IPCϩNF, respectively). None of the treatments used in these protocols affected cell mortality in time-matched nonischemic baseline cardiomyocytes (data not shown). Similar results were obtained in 48-hour cultured cardiomyocytes ( Figure 2B) . 22. 2Ϯ1.8% vs control (C CM ) 52.2Ϯ1.3%]. BaCl 2 (20 mol/L), in the presence of nifedipine (NF), abolished IPC protection (IPC CM ϩBaCl 2 46.6Ϯ3.2% vs IPC CM ), while it did not affect mortality in controls (C CM ϩBaCl 2 50.9Ϯ1.4% vs C CM ). Nifedipine alone neither affected controls (C CM ϩNF 50.8Ϯ1.2% vs C CM ) nor blocked IPC protection (IPC CM ϩNF 21.5Ϯ2.8% vs C CM ϩNF). *PϽ0.0001 vs C CM , C CM ϩNF; #PϽ0.0001 vs IPC. All data presented in A and B were obtained from 4 to 5 cardiomyocyte isolations (nϭ4 to 5 hearts) in each cell model, respectively. Data are expressed as meanϮSEM.
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Blockade of Ischemic Preconditioning Protection by Targeted Knockdown of I K1 Channel Subunits (Kir2.1 and Kir2.2) in Cultured Ventricular Cardiomyocytes
Because barium may not be completely specific for I K1 channel blockade, 19 we utilized a more definitive molecular approach to confirm the role of I K1 channels in IPC. Cardiomyocytes were transfected with either a dominant-negative gene (AdEGFPKir2.1DN or AdEGFPKir2.2DN) to knockdown I K1 channels or the AdEGFP gene as control. The percentage of dead cardiomyocytes did not differ among the different groups before the long SI/SR (Figure 3 ). In addition, the percentage of dead cardiomyocytes did not change over time (160 minutes) when cardiomyocytes were kept in oxygenated conditions at 37°C (data not shown). Knockdown of I K1 channels by either AdEGFPKir2.1DN or AdEGFPKir2.2DN abolished IPC protection (Figure 3 ) when compared with cardiomyocytes transfected with the reporter gene (AdEGFP) alone or with nontransfected cardiomyocytes. Transfection of cardiomyocytes with AdEGFP neither changed cardiomyocyte mortality in controls (nonpreconditioned) nor affected IPC protection in cardiomyocytes.
Effect of Sarcolemmal I KATP Channel Blockade on Ischemic Preconditioning Cardioprotection
To determine if in our cardiomyocyte culture model sI KATP channels were important for IPC, we tested whether blockade of these channels eliminated IPC protection in both freshly isolated cardiomyocytes and 48-hour cultured cardiomyocytes. Selective blockade of sI KATP channels with 30 mol/L HMR1098 had no effect on the protection by IPC, as shown in Figure 4A and 4B. HMR1098 alone did not affect cell viability in baseline cardiomyocytes in either cell model (data not shown).
Discussion
The present study defines a role for I K1 channels in the protection produced by ischemic preconditioning (IPC). We show that inhibition of I K1 channels with Ba 2ϩ or genetic knockdown of I K1 channels using a dominant-negative approach abolishes IPC protection against ischemic cell death in cultured rabbit ventricular cardiomyocytes. An initial concern in using Ba 2ϩ to inhibit I K1 currents was the possible toxic effects of this agent on cardiomyocytes. Indeed, in pilot studies, we observed barium-associated increase of necrosis in cardiomyocytes under baseline conditions. This necrosis above baseline levels was prevented by treatment with nifedipine to block L-type calcium channels. Importantly, nifedipine did not interfere with the protective response to preconditioning nor did it produce a protective effect under control conditions. Although Ba 2ϩ is a relatively nonspecific blocker of K ϩ currents, it is unlikely that the inhibition of IPC protection by Ba 2ϩ application in our cardiomyocyte studies is a consequence of blockade of voltage-gated K ϩ channels because the cardiomyocytes were electrically quiescent. On the other hand, Ba 2ϩ at levels used in our studies (20 mol/L) can inhibit (40% to 50%) of I KATP current at hyperpolarized membrane potentials (Ϫ100 mV) although there is minimal inhibition at membrane potentials close to the resting poten- tial. 19 Consistent with this conclusion, we found that inhibition of sI KATP with HMR1098 did not abolish IPC protection under our experimental conditions, supporting that Ba 2ϩinduced blockade of IPC was not the result of sI KATP blockade by Ba 2ϩ . Because Ba 2ϩ is known to be a potent inhibitor of cardiac I K1 currents, our present cardiomyocyte studies suggest that I K1 channels play a pivotal role in IPC.
Adenovirus overexpression of either Kir2.1DN or Kir2.2DN dominant-negative channels was equally effective at reducing I K1 currents in cultured rabbit ventricular cardiomyocytes. The equivalent reduction of I K1 currents observed with overexpression of these two dominant-negative genes are consistent with our previous study, 16 suggesting that cardiac I K1 channels appear to be predominantly composed of heterotetramers of Kir2.1 and Kir2.2 channels. Furthermore, because we previously showed that overexpression of these two dominant-negative genes did not affect voltage-gated K ϩ currents in cultured cardiomyocytes, 16 it would appear that these dominant-negative genes caused specific reductions in I K1 currents.
Because the amplitude of the I K1 current is diminished in cardiomyocytes after 2 to 3 days in culture when compared with the I K1 current in freshly isolated cardiomyocytes, 20 -22 one may question whether 48-hour cultured cardiomyocytes are appropriate for studying the role of I K1 channel in IPC. In fact, despite a significant reduction of I K1 current density to about half that in control cardiomyocytes overexpressing the EGFP gene after 48 hours in culture (Figure 1) , IPC protection against ischemic cell death was as potent as observed in freshly isolated cardiomyocytes (Figures 2A and 4A) . These results suggest that a critical level of I K1 current is necessary for IPC to occur and that only reductions below this critical "threshold" level will lead to inhibition of IPC. Consistent with this suggestion, the absolute level of I K1 current remaining in freshly isolated cardiomyocytes after inhibition with Ba 2ϩ during our IPC studies is estimated to be similar to that present in cultured cardiomyocytes after dominant-negative knockdown of I K1 . Specifically (also see online data supplement for further details), by accounting for the voltagedependence of I K1 block by Ba 2ϩ as well as the changes in resting membrane potential of cardiomyocytes in our IPC studies (ie, Ϫ65 to Ϫ50 mV) due to K ϩ accumulation, I K1 currents in our IPC studies with Ba 2ϩ are estimated to be reduced by about 86% to 87% compared with a 75% to 80% reduction in I K1 density recorded in cultured cardiomyocytes expressing dominant-negative Kir2.1/2 genes. It is possible that the extent of I K1 inhibition necessary to block IPC protection may depend on the experimental conditions used (ie, fresh versus cultured cardiomyocytes), possibly as a result of a change in threshold of I K1 current required to support IPC. Further studies will be necessary to fully unravel the dependence of IPC on the absolute level of I K1 activity.
The results of the present study contrast with previous findings by Schultz et al 23 who showed that a bolus intravenous administration of terikalant, an I K1 channel blocker, 15 minutes before the long ischemia in vivo did not block ischemic preconditioning in anesthetized rats. This discrepancy could be due either to species differences (rat versus rabbit) in the role of I K1 channels or, more likely, to inadequate I K1 blockade by terikalant in that study. Indeed, terikalant is a relatively weak blocker of inward rectifier K ϩ channels in cardiomyocytes 24 and Schultz et al 23 could only block 39% of I K1 current in guinea-pig ventricular cardiomyocytes with 30 mol/L terikalant, which was the concentration selected to avoid simultaneous blockade of I K1 and sI KATP channels. As described earlier, our data suggest that this level of inhibition is insufficient to block IPC protection. Furthermore, terikalant also blocks I Kr at micromolar concentrations, 25 although this is unlikely to explain the inability of terikalant to block IPC-mediated cardioprotection. 23 The regulatory signaling underlying the protection produced by I K1 currents against ischemic injury in our studies could involve several mechanisms. We have recently demonstrated that enhanced cell volume regulation is a key mechanism of IPC cardioprotection. 7 Combining these results with our previous observations that Cl Ϫ channel inhibition blocks the protection against myocardial necrosis of both ischemic 8 and pharmacological 6 preconditioning suggests that outward Cl Ϫ movement is involved in protecting cardiomyocytes from ischemic injury. Because ionic balance (electroneutrality) is required for volume regulation, our results suggest that I K1 currents are required for IPC as a consequence of contribution to volume regulation. The direct contribution of I K1 channels to cell volume regulation in cardiomyocytes remains to be investigated and is beyond the scope of the present study. Recently, Irie et al 26 reported that preconditioning in single guinea pig cardiomyocytes produced a significant reduction in the average time for induction (ie, early activation) of outward K ϩ current in response to simulated ischemia. These results are consistent with I K1 as a source for the outward K ϩ movement they have demonstrated.
To the extent to which enhanced cell volume regulation during ischemic stress is responsible for IPC protection against ischemia/reperfusion injury, transsarcolemmal K ϩ efflux in quiescent cultured cardiomyocytes could arise from background K ϩ currents other that I K1 , most notably sI KATP . Addressing this issue, we found that sI KATP blockade with HMR1098 did not inhibit IPC in freshly isolated or 48-hour cultured quiescent cardiomyocytes. Under in vivo conditions, the role of sI KATP in IPC has been controversial. Consistent with the present study, blockade of sI KATP with HMR1883, of which HMR 1098 is the sodium salt, did not abolish the protective effect of IPC in rabbit hearts. 27 Nevertheless, it has been shown that in Kir6.2 knockout mice lacking sI KATP channels, IPC failed to protect from myocardial necrosis 28 and failed to improve postischemic functional performance. 29, 30 A more intense and rapid contracture has been reported to occur during the index ischemia in the Kir6.2 knockouts than in control hearts with subsequent functional recovery much worse than control, in the absence of preconditioning. 31 It is clear that knockout of sI KATP channels results in a poor response of the myocardium to ischemic challenge under control conditions, likely shifting ischemic injury to higher levels. This makes it difficult to determine if sI KATP is playing a specific role in IPC protection. It remains possible that both sI KATP and I K1 , in combination, may be contributing to IPC protection in vivo through enhanced cardiomyocyte cell volume regulation. Because our experimental results are limited to fresh and cultured cardiomyocyte models, some caution is warranted in extrapolation to the whole heart. Other K ϩ channels and transporters might also contribute to K ϩ efflux under ischemic conditions. Also, the precise quantitative connection among K ϩ efflux, I K1 density and preconditioning requires further investigation.
Other than sI KATP , to date the putative ATP-sensitive mitochondrial K ϩ (mitoK ATP ) channel has been the primary focus of interest and controversy in regard to ion channels in IPC. Whatever the possible role of mitoK ATP in IPC may be, it cannot, alone, account for the protection against necrosis afforded by IPC based on a recent review of the literature by Gross and Peart. 32 Furthermore, there is no evidence that the I K1 channel is expressed in mitochondria; therefore, involvement of mitochondria in the action of I K1 in IPC, if any, would have to be indirect, conceivably through a signaling pathway terminating on the I K1 channel.
In conclusion, our results indicate that I K1 channels play an important role in the protection induced by ischemic preconditioning and support the I K1 channel as a strong candidate for the role as one end effector in ischemic preconditioning of the myocardium.
